{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T02:40:52Z","timestamp":1785552052859,"version":"3.56.0"},"reference-count":22,"publisher":"MDPI AG","issue":"3","license":[{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Spanish Instituto de Salud Carlos III-European FEDER funds","award":["RICOR2040-RD21\/0005\/0011"],"award-info":[{"award-number":["RICOR2040-RD21\/0005\/0011"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCM"],"abstract":"<jats:p>Background: Cardiovascular comorbidity is a common companion of psoriasis and psoriatic arthritis (PsA). Recently, a significant link has been found between the HLA-Cw6 allele and a better cardiometabolic profile in these patients. We aimed to check this finding in our setting. Methods: A cross-sectional observational study (n: 572 psoriasis patients, 30% with PsA) was conducted. Different study variables were collected in detail, as well as classic cardiometabolic risk factors. The distribution of the HLA-Cw6 allele and the IFIH1\/MDA5 gene variants previously linked to disease risk were determined in the study cohort and stratified according to the cardiometabolic comorbidity. Linear and logistic regression models were constructed to analyze these associations. Results: The study cohort included 309 men and 263 women, with a mean age of 46.7 years (SD 14.5) and a mean disease duration of 19.4 years (SD 14.8). We confirmed the known association between HLA-Cw6 and type I psoriasis (familial, severe, and early onset). Psoriasis severity (OR: 2.14), female sex (OR: 1.63), and the IFIH1\/MDA5 rs1990760 TT genotype (OR: 1.62) were significantly related to PsA, while HLA-Cw6 was protective (OR: 0.65). HLA-Cw6 carriers showed a lower waist perimeter, lower BMI, and lower risk of both hypertension (OR: 0.52, p &lt; 0.001) and diabetes (OR: 0.36, p &lt; 0.001), but these findings were no longer apparent upon adjusting the regression models. No IFIH1\/MDA5 gene variant was associated with any cardiometabolic risk factor. Conclusions: The influence of HLA-Cw6 on the cardiometabolic risk profile of psoriatic patients seems to be explained by other factors (age, sex, duration of the disease or arthritis) and not by this biomarker itself.<\/jats:p>","DOI":"10.3390\/jcm13030845","type":"journal-article","created":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T09:43:22Z","timestamp":1706780602000},"page":"845","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Influence of the HLA-Cw6 Allele and IFIH1\/MDA5 Gene Variants on the Cardiometabolic Risk Profile of Patients with Psoriatic Disease"],"prefix":"10.3390","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8418-7145","authenticated-orcid":false,"given":"Rub\u00e9n","family":"Queiro","sequence":"first","affiliation":[{"name":"Rheumatology Division, Hospital Universitario Central de Asturias (HUCA), 33011 Oviedo, Spain"},{"name":"Translational Immunology Division, Health Research Institute of Asturias, 33011 Oviedo, Spain"},{"name":"Department of Medicine, Faculty of Medicine, Oviedo University, 33011 Oviedo, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ignacio","family":"Bra\u00f1a","sequence":"additional","affiliation":[{"name":"Rheumatology Division, Hospital Universitario Central de Asturias (HUCA), 33011 Oviedo, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Estefan\u00eda","family":"Pardo","sequence":"additional","affiliation":[{"name":"Rheumatology Division, Hospital Universitario Central de Asturias (HUCA), 33011 Oviedo, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Loredo","sequence":"additional","affiliation":[{"name":"Rheumatology Division, Hospital Universitario Central de Asturias (HUCA), 33011 Oviedo, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefanie","family":"Burger","sequence":"additional","affiliation":[{"name":"Rheumatology Division, Hospital Universitario Central de Asturias (HUCA), 33011 Oviedo, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-4448-4690","authenticated-orcid":false,"given":"Pablo","family":"Gonz\u00e1lez del Pozo","sequence":"additional","affiliation":[{"name":"Rheumatology Division, Hospital Universitario Central de Asturias (HUCA), 33011 Oviedo, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paula","family":"Alvarez","sequence":"additional","affiliation":[{"name":"Rheumatology Division, Hospital Universitario Central de Asturias (HUCA), 33011 Oviedo, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5972-8763","authenticated-orcid":false,"given":"Eva","family":"Fern\u00e1ndez-Bret\u00f3n","sequence":"additional","affiliation":[{"name":"Biostatistics and Epidemiology Platform, Health Research Institute of Asturias, 33011 Oviedo, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pablo","family":"Coto","sequence":"additional","affiliation":[{"name":"Dermatology Division, Hospital Vital Alvarez Buylla, 33611 Mieres, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8649-9150","authenticated-orcid":false,"given":"Eliecer","family":"Coto","sequence":"additional","affiliation":[{"name":"Department of Medicine, Faculty of Medicine, Oviedo University, 33011 Oviedo, Spain"},{"name":"Molecular Genetic Unit, Hospital Universitario Central Asturias (HUCA), 33011 Oviedo, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2024,2,1]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1056\/NEJMra1505557","article-title":"Psoriatic Arthritis","volume":"376","author":"Ritchlin","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"24","DOI":"10.3899\/jrheum.150629","article-title":"Psoriatic Disease: Clinical Staging","volume":"93","author":"Scarpa","year":"2015","journal-title":"J. Rheumatol. Suppl."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1111\/bjd.16083","article-title":"HLA-Cw6 and psoriasis","volume":"178","author":"Chen","year":"2018","journal-title":"Br. J. Dermatol."},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"Queiro, R., Coto-Segura, P., Bra\u00f1a, I., Pino, M., and Burger, S. (2022). Potential Differences in the Cardiometabolic Risk Profile of Patients with Psoriatic Disease according to Their HLA-C\u221706 Status. Biomed. Res. Int., 2022.","DOI":"10.1155\/2022\/1451193"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1016\/j.jid.2021.08.446","article-title":"Differences in Clinical Features and Comorbid Burden between HLA-C\u221706:02 Carrier Groups in >9000 People with Psoriasis","volume":"142","author":"Douroudis","year":"2022","journal-title":"J. Investig. Dermatol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"adv5209","DOI":"10.2340\/actadv.v103.5209","article-title":"Body Composition, Cardiometabolic Risk Factors and Comorbidities in Psoriasis and the Effect of HLA-C*06:02 Status: The HUNT Study, Norway","volume":"103","author":"Solvin","year":"2023","journal-title":"Acta Derm. Venereol."},{"key":"ref_7","first-page":"1179","article-title":"HLA-Cw6 allele and biologic therapy are protective factors against liver fibrosis in psoriatic arthritis patients","volume":"41","year":"2023","journal-title":"Clin. Exp. Rheumatol."},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"Queiro, R., Bra\u00f1a, I., Loredo, M., and Burger, S. (2023). HLA-C*06-defined endotype in psoriatic disease: An ever-widening landscape. Rheumatology, kead572. online ahead of print.","DOI":"10.1093\/rheumatology\/kead572"},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Coto-Segura, P., V\u00e1zquez-Coto, D., Vel\u00e1zquez-Cuervo, L., Garc\u00eda-Lago, C., Coto, E., and Queiro, R. (2023). The IFIH1\/MDA5 rs1990760 Gene Variant (946Thr) Differentiates Early- vs. Late-Onset Skin Disease and Increases the Risk of Arthritis in a Spanish Cohort of Psoriasis. Int. J. Mol. Sci., 24.","DOI":"10.20944\/preprints202306.0016.v1"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"e611","DOI":"10.1111\/jdv.18870","article-title":"Association between HLA-Cw6 and response to treatment with biologics in patients with psoriasis: A systematic review and meta-analysis","volume":"37","author":"Siewertsen","year":"2023","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Inerot, A., Enerb\u00e4ck, C., Enlund, F., Martinsson, T., Samuelsson, L., Wahlstr\u00f6m, J., and Swanbeck, G. (2005). Collecting a set of psoriasis family material through a patient organisation; clinical characterisation and presence of additional disorders. BMC Dermatol., 5.","DOI":"10.1186\/1471-5945-5-10"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"108397","DOI":"10.1016\/j.clim.2020.108397","article-title":"Comorbidities associated with psoriatic arthritis: Review and update","volume":"214","author":"Merola","year":"2020","journal-title":"Clin. Immunol."},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Puig, L. (2017). Cardiometabolic Comorbidities in Psoriasis and Psoriatic Arthritis. Int. J. Mol. Sci., 19.","DOI":"10.3390\/ijms19010058"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1080\/1744666X.2020.1740593","article-title":"Metabolic Syndrome and psoriatic arthritis: Considerations for the clinician","volume":"16","author":"Caso","year":"2020","journal-title":"Expert. Rev. Clin. Immunol."},{"key":"ref_15","first-page":"504","article-title":"Prevalence of psoriasis in Spain in the age of biologics","volume":"105","author":"Carrascosa","year":"2014","journal-title":"Actas Dermosifiliogr."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1007\/s40618-022-01755-0","article-title":"Risk of non-alcoholic fatty liver disease in patients with chronic plaque psoriasis: An updated systematic review and meta-analysis of observational studies","volume":"45","author":"Bellinato","year":"2022","journal-title":"J. Endocrinol. Investig."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"6565","DOI":"10.1038\/s41467-022-34323-4","article-title":"Shared genetic risk factors and causal association between psoriasis and coronary artery disease","volume":"13","author":"Patrick","year":"2022","journal-title":"Nat. Commun."},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Piaserico, S., Orlando, G., and Messina, F. (2022). Psoriasis and Cardiometabolic Diseases: Shared Genetic and Molecular Pathways. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms23169063"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1038\/jid.2015.8","article-title":"Psoriasis and cardiometabolic traits: Modest association but distinct genetic architectures","volume":"135","author":"Koch","year":"2015","journal-title":"J. Investig. Dermatol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1844","DOI":"10.3899\/jrheum.151469","article-title":"The Association of HLA-class I Genes and the Extent of Atherosclerotic Plaques in Patients with Psoriatic Disease","volume":"43","author":"Eder","year":"2016","journal-title":"J. Rheumatol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"2063","DOI":"10.1007\/s10067-019-04519-z","article-title":"Hypertension is associated with increased age at the onset of psoriasis and a higher body mass index in psoriatic disease","volume":"38","author":"Queiro","year":"2019","journal-title":"Clin. Rheumatol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"3949","DOI":"10.1093\/rheumatology\/keab365","article-title":"Hyperlipidaemia in psoriatic disease: Higher prevalence in psoriatic arthritis and inverse association with systemic therapy","volume":"60","author":"Queiro","year":"2021","journal-title":"Rheumatology"}],"container-title":["Journal of Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2077-0383\/13\/3\/845\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T13:53:03Z","timestamp":1760104383000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2077-0383\/13\/3\/845"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2,1]]},"references-count":22,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2024,2]]}},"alternative-id":["jcm13030845"],"URL":"https:\/\/doi.org\/10.3390\/jcm13030845","relation":{},"ISSN":["2077-0383"],"issn-type":[{"value":"2077-0383","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,2,1]]}}}